![Medtronic PROTECTA XT DR D314DRG Clinician Manual Download Page 117](http://html.mh-extra.com/html/medtronic/protecta-xt-dr-d314drg/protecta-xt-dr-d314drg_clinician-manual_1763148117.webp)
5.5 Performing ventricular defibrillation threshold tests
To test the ventricular defibrillation operation and effectiveness of the implanted lead
system, induce VF using either the T-Shock or the 50 Hz Burst method and allow the device
to detect and treat the VF using the programmed automatic therapies. Follow the
instructions for your preferred method to establish that an adequate sensing safety margin
and an adequate defibrillation safety margin exist.
5.5.1 High-voltage implant values
See Table 11 for information about the measured high-voltage therapy values that are
recommended at implant.
Table 11. High-voltage therapy values recommended at implant
Measurement
Acute or chronic leads
HV delivery pathway impedance
20–200 Ω
Defibrillation threshold
≤ 25 J
5.5.2 How to prepare for defibrillation threshold testing
Warning: Keep external defibrillation equipment nearby for immediate use. Potentially
harmful spontaneous or induced tachyarrhythmias may occur during device testing, implant
procedures, and post-implant testing.
1. Establish telemetry between the device and programmer, and start a patient session.
If you are using wireless telemetry, verify that at least 3 of the green lights on the
wireless telemetry icon are illuminated. Interrogate the device if it has not been
interrogated.
2. Select the Params icon, select the VF Therapies field, and then select [Shared
Settings…]. Program the Active Can/SVC Coil parameter to On or Off, as is appropriate
for the patient.
3. Observe the Marker Channel annotations to verify that the device is sensing properly.
Medtronic
PROTECTA™ XT DR D314DRG
Clinician Manual
117
Summary of Contents for PROTECTA XT DR D314DRG
Page 2: ......
Page 9: ...Index 488 Medtronic PROTECTA XT DR D314DRG Clinician Manual 9 ...
Page 506: ......
Page 507: ......